These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34187934)

  • 1. CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP.
    Nishiyama K; Maekawa M; Nakagita T; Nakayama J; Kiyoi T; Chosei M; Murakami A; Kamei Y; Takeda H; Takada Y; Higashiyama S
    Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34187934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cullin-3/KCTD10 E3 complex is essential for Rac1 activation through RhoB degradation in human epidermal growth factor receptor 2-positive breast cancer cells.
    Murakami A; Maekawa M; Kawai K; Nakayama J; Araki N; Semba K; Taguchi T; Kamei Y; Takada Y; Higashiyama S
    Cancer Sci; 2019 Feb; 110(2):650-661. PubMed ID: 30515933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cullin-3-Rbx1-KCTD10 complex controls endothelial barrier function via K63 ubiquitination of RhoB.
    Kovačević I; Sakaue T; Majoleé J; Pronk MC; Maekawa M; Geerts D; Fernandez-Borja M; Higashiyama S; Hordijk PL
    J Cell Biol; 2018 Mar; 217(3):1015-1032. PubMed ID: 29358211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models.
    Xia W; Petricoin EF; Zhao S; Liu L; Osada T; Cheng Q; Wulfkuhle JD; Gwin WR; Yang X; Gallagher RI; Bacus S; Lyerly HK; Spector NL
    Breast Cancer Res; 2013; 15(5):R85. PubMed ID: 24044505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCTD10 Biology: An Adaptor for the Ubiquitin E3 Complex Meets Multiple Substrates: Emerging Divergent Roles of the cullin-3/KCTD10 E3 Ubiquitin Ligase Complex in Various Cell Lines.
    Maekawa M; Higashiyama S
    Bioessays; 2020 Aug; 42(8):e1900256. PubMed ID: 32484264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neddylation-cullin 2-RBX1 E3 ligase axis targets tumor suppressor RhoB for degradation in liver cancer.
    Xu J; Li L; Yu G; Ying W; Gao Q; Zhang W; Li X; Ding C; Jiang Y; Wei D; Duan S; Lei Q; Li P; Shi T; Qian X; Qin J; Jia L
    Mol Cell Proteomics; 2015 Mar; 14(3):499-509. PubMed ID: 25540389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoB protects human keratinocytes from UVB-induced apoptosis through epidermal growth factor receptor signaling.
    Canguilhem B; Pradines A; Baudouin C; Boby C; Lajoie-Mazenc I; Charveron M; Favre G
    J Biol Chem; 2005 Dec; 280(52):43257-63. PubMed ID: 16278215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
    Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR
    J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer.
    Lee YJ; Ho SR; Graves JD; Xiao Y; Huang S; Lin WC
    Breast Cancer Res; 2019 Dec; 21(1):134. PubMed ID: 31801577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism.
    Calvayrac O; Mazières J; Figarol S; Marty-Detraves C; Raymond-Letron I; Bousquet E; Farella M; Clermont-Taranchon E; Milia J; Rouquette I; Guibert N; Lusque A; Cadranel J; Mathiot N; Savina A; Pradines A; Favre G
    EMBO Mol Med; 2017 Feb; 9(2):238-250. PubMed ID: 28003335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arf6 regulates RhoB subcellular localization to control cancer cell invasion.
    Zaoui K; Rajadurai CV; Duhamel S; Park M
    J Cell Biol; 2019 Nov; 218(11):3812-3826. PubMed ID: 31591185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
    Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
    Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2).
    Hartman Z; Geldenhuys WJ; Agazie YM
    J Biol Chem; 2020 Mar; 295(11):3563-3575. PubMed ID: 32024694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.
    Yao Z; Darowski K; St-Denis N; Wong V; Offensperger F; Villedieu A; Amin S; Malty R; Aoki H; Guo H; Xu Y; Iorio C; Kotlyar M; Emili A; Jurisica I; Neel BG; Babu M; Gingras AC; Stagljar I
    Mol Cell; 2017 Jan; 65(2):347-360. PubMed ID: 28065597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant-induced INrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degradation of the INrf2-Cul3-Rbx1 complex to allow normal Nrf2 activation and repression.
    Kaspar JW; Niture SK; Jaiswal AK
    J Cell Sci; 2012 Feb; 125(Pt 4):1027-38. PubMed ID: 22448038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
    Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
    Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2 oncogenic function escapes EGFR tyrosine kinase inhibitors via activation of alternative HER receptors in breast cancer cells.
    Kong A; Calleja V; Leboucher P; Harris A; Parker PJ; Larijani B
    PLoS One; 2008 Aug; 3(8):e2881. PubMed ID: 18682844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis.
    Kazerounian S; Gerald D; Huang M; Chin YR; Udayakumar D; Zheng N; O'Donnell RK; Perruzzi C; Mangiante L; Pourat J; Phung TL; Bravo-Nuevo A; Shechter S; McNamara S; Duhadaway JB; Kocher ON; Brown LF; Toker A; Prendergast GC; Benjamin LE
    Cancer Res; 2013 Jan; 73(1):50-61. PubMed ID: 23135917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling.
    Asbagh LA; Vazquez I; Vecchione L; Budinska E; De Vriendt V; Baietti MF; Steklov M; Jacobs B; Hoe N; Singh S; Imjeti NS; Zimmermann P; Sablina A; Tejpar S
    Oncotarget; 2014 Oct; 5(20):10070-83. PubMed ID: 25301722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.